{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:28Z","timestamp":1791308848586,"version":"4.3.1"},"reference-count":152,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Tuberc"],"abstract":"<jats:p>Although Bacillus Calmette-Gu\u00e9rin (BCG) vaccine, the only licensed vaccine against tuberculosis (TB), is the most widely used vaccine worldwide, TB is the second leading global killer from a single infectious agent responsible for over one million deaths annually. With the increasing threat of the emergence of drug-resistant TB, there is intense research toward better and more efficacious vaccines against TB. Indeed, TB vaccine research has blossomed in recent years: demonstration of sterilizing immunity against <jats:italic>Mycobacterium tuberculosis (Mtb)<\/jats:italic> challenge in non-human primates, the potential benefit of BCG revaccination in humans, and a phase IIb vaccine with ~50% efficacy against developing active disease. Consequently, several vaccines are set to begin phase 3 trials in 2024, and new candidates have entered phase 1 including mRNA-based TB vaccines. However, despite the enthusiasm, there are no known correlates of protection against TB, the antigens that induce protective immunity are incompletely defined, and the overreliance on Th1 cytokine production as an \u201cabsolute\u201d measure of protection is increasingly debatable. In this perspective, I highlight the recent milestones in TB Vaccine research and the remaining challenges and propose suggestions for future considerations.<\/jats:p>","DOI":"10.3389\/ftubr.2024.1435344","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:57:09Z","timestamp":1721365029000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A broader evaluation of vaccine-induced T cell immunity against tuberculosis"],"prefix":"10.3389","volume":"2","author":[{"given":"Paul","family":"Ogongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"B1","unstructured":"2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"a017822","DOI":"10.1101\/cshperspect.a017822","article-title":"Tuberculosis treatment and drug regimens","volume":"5","author":"Sotgiu","year":"2015","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13012-020-01025-8","article-title":"Protocol for the 3HP options trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda","volume":"15","author":"Kadota","year":"2020","journal-title":"Implement Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa2033400","article-title":"Four-month rifapentine regimens with or without moxifloxacin for tuberculosis","volume":"384","author":"Dorman","year":"2021","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat Rev Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40249-023-01107-x","article-title":"Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Salari","year":"2023","journal-title":"Infect Dis Pover."},{"key":"B8","doi-asserted-by":"publisher","first-page":"20201635","DOI":"10.1098\/rspb.2020.1635","article-title":"Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease","volume":"288","author":"Emery","year":"2021","journal-title":"Proc R Soc B."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/s41564-024-01683-0","article-title":"Rethinking the burden of latent tuberculosis to reprioritize research","volume":"9","author":"Behr","year":"2024","journal-title":"Nat Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur Respir J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S2213-2600(24)00028-6","article-title":"Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise","volume":"12","author":"Coussens","year":"2024","journal-title":"Lancet Respir Med."},{"key":"B13","unstructured":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e148291","DOI":"10.1172\/JCI148291","article-title":"BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases","volume":"131","author":"Singh","year":"2021","journal-title":"J Clin Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","article-title":"BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment","volume":"28","author":"Cirovic","year":"2020","journal-title":"Cell Host Microbe."},{"key":"B19","doi-asserted-by":"publisher","first-page":"107634","DOI":"10.1016\/j.celrep.2020.107634","article-title":"\u03b2-glucan induces protective trained immunity against Mycobacterium tuberculosis infection: a key role for IL-1","volume":"31","author":"Moorlag","year":"2020","journal-title":"Cell Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.immuni.2023.12.005","article-title":"Multi-omics analysis of innate and adaptive responses to BCG vaccination reveals epigenetic cell states that predict trained immunity","volume":"57","author":"Moorlag","year":"2024","journal-title":"Immunity."},{"key":"B21","doi-asserted-by":"publisher","first-page":"jiae089","DOI":"10.1093\/infdis\/jiae089","article-title":"Estimating the potential public health value of BCG revaccination","volume":"2024","author":"Clark","year":"2024","journal-title":"J Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.vaccine.2024.01.072","article-title":"Modelling the health and economic impacts ofM72\/AS01E vaccination and BCG-revaccination: Estimates for South Africa","volume":"42","author":"Sumner","year":"2024","journal-title":"Vaccine."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1016\/j.vaccine.2017.07.073","article-title":"A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice","volume":"35","author":"Ahmed","year":"2017","journal-title":"Vaccine."},{"key":"B24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4049\/jimmunol.2100029","article-title":"Mucosal vaccination with cyclic dinucleotide adjuvants induces effective T cell homing and IL-17-dependent protection against Mycobacterium tuberculosis infection","volume":"208","author":"Jong","year":"2022","journal-title":"J Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41541-023-00666-2","article-title":"A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG","volume":"8","author":"Dijkman","year":"2023","journal-title":"NPJ Vaccines."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1038\/s41467-021-26934-0","article-title":"A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Gu\u00e9rin","volume":"12","author":"Woodworth","year":"2021","journal-title":"Nat Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2023.1246826","article-title":"Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates","author":"White","year":"2023","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/vaccines11081304","article-title":"Next-generation TB vaccines: progress, challenges, and prospects","volume":"11","author":"Zhuang","year":"2023","journal-title":"Vaccines (Basel)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fimmu.2023.1238649","article-title":"Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates","author":"Zhou","year":"2023","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-023-00750-7","article-title":"Key advances in vaccine development for tuberculosis\u2014success and challenges","volume":"8","author":"Lai","year":"2023","journal-title":"NPJ Vaccines."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e155655","DOI":"10.1172\/jci.insight.155655","article-title":"Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans","volume":"7","author":"Jeyanathan","year":"2022","journal-title":"JCI Insight."},{"key":"B34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/trstmh\/tru206","article-title":"Aerosol immunisation for TB: matching route of vaccination to route of infection","volume":"109","author":"Manjaly Thomas","year":"2015","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/mt.2008.59","article-title":"Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine","volume":"16","author":"Roediger","year":"2008","journal-title":"Mol Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.tube.2016.09.004","article-title":"Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations","volume":"101","author":"Sharpe","year":"2016","journal-title":"Tuberculosis (Edinb)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"8533","DOI":"10.1038\/ncomms9533","article-title":"Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosis","volume":"6","author":"Kaushal","year":"2015","journal-title":"Nat Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.femsim.2005.02.009","article-title":"Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis FEMS","volume":"45","author":"Giri","year":"2005","journal-title":"Immunol Med Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"14621","DOI":"10.4049\/jimmunol.196.Supp.146.21","article-title":"Vaccination route has an impact on level of protection of non-human primates from tuberculosis","volume":"196","author":"Wong","year":"2016","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/s41564-023-01503-x","article-title":"Intravenous Bacille Calmette-Gu\u00e9rin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis","volume":"8","author":"Larson","year":"2023","journal-title":"Nat Microbiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Gu\u00e9rin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"Ankara J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"617892","DOI":"10.1155\/2011\/617892","article-title":"Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein","volume":"2011","author":"Lu","year":"2011","journal-title":"Clin Dev Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.ymthe.2017.02.018","article-title":"Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice","volume":"25","author":"Hu","year":"2017","journal-title":"Mol Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"130540","DOI":"10.1172\/jci.insight.130540","article-title":"BCG revaccination boosts adaptive polyfunctional Th1\/Th17 and innate effectors in IGRA+ and IGRA- Indian adults","volume":"4","author":"Rakshit","year":"2019","journal-title":"JCI Insight."},{"key":"B48","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1473-3099(24)00006-9","article-title":"Revaccination with BCG: does it work?","volume":"24","author":"McShane","year":"2024","journal-title":"Lancet Inf Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1016\/j.vaccine.2011.05.023","article-title":"Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial","volume":"29","author":"Barreto","year":"2011","journal-title":"Vaccine."},{"key":"B51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fimmu.2018.00346","article-title":"Mucosal delivery of fusion proteins with bacillus subtilis spores enhances protection against tuberculosis by bacillus Calmette-Gu\u00e9rin","volume":"9","author":"Copland","year":"2018","journal-title":"Front Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1128\/IAI.00786-13","article-title":"Mucosal vaccination against tuberculosis using inert bioparticles","volume":"81","author":"Reljic","year":"2013","journal-title":"Infect Immun."},{"key":"B53","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.chom.2023.05.006","article-title":"Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques","volume":"31","author":"Darrah","year":"2023","journal-title":"Cell Host Microbe."},{"key":"B54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tube.2017.02.003","article-title":"Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails","volume":"104","author":"Verreck","year":"2017","journal-title":"Tuberculosis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"100187","DOI":"10.1016\/j.xcrm.2020.100187","article-title":"Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection","volume":"2","author":"Dijkman","year":"2021","journal-title":"Cell Rep Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1128\/CVI.00700-13","article-title":"Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination","volume":"21","author":"Aguilo","year":"2014","journal-title":"Clin Vaccine Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/infdis\/jiv503","article-title":"Pulmonary but not subcutaneous delivery of BCG vaccine confers protection to tuberculosis-susceptible mice by an interleukin 17-dependent mechanism","volume":"213","author":"Aguilo","year":"2016","journal-title":"J Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.01686-16","article-title":"Mucosal BCG vaccination induces protective lung-resident memory T cell populations against tuberculosis","volume":"7","author":"Perdomo","year":"2016","journal-title":"MBio."},{"key":"B59","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","article-title":"Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques","volume":"25","author":"Dijkman","year":"2019","journal-title":"Nat Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.chom.2020.10.003","article-title":"Ultra-low dose aerosol infection of mice with Mycobacterium tuberculosis more closely models human tuberculosis","volume":"29","author":"Plumlee","year":"2021","journal-title":"Cell Host Microbe."},{"key":"B61","doi-asserted-by":"publisher","first-page":"972","DOI":"10.5588\/ijtld.18.0173","article-title":"Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878-1940","volume":"22","author":"Donald","year":"2018","journal-title":"Int J Tuberc Lung Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0962-8479(94)90002-7","article-title":"Pathogenesis of tuberculosis: pathway to apical localization","volume":"75","author":"Balasubramanian","year":"1994","journal-title":"Tuber Lung Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b Controlled Trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S1473-3099(23)00818-6","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial","volume":"24","author":"Dos Santos","year":"2024","journal-title":"Lancet Infect Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi","volume":"348","year":"1996","journal-title":"Lancet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/S2213-2600(24)00009-2","article-title":"What is next for BCG revaccination to prevent tuberculosis?","volume":"12","author":"White","year":"2024","journal-title":"Lancet Respir Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s41590-021-01066-1","article-title":"Robust IgM responses following intravenous vaccination with Bacille Calmette-Gu\u00e9rin associate with prevention of Mycobacterium tuberculosis infection in macaques","volume":"22","author":"Irvine","year":"2021","journal-title":"Nat Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1011648","DOI":"10.1371\/journal.pcbi.1011648","article-title":"The MAGMA pipeline for comprehensive genomic analyses of clinical Mycobacterium tuberculosis samples","volume":"19","author":"Heupink","year":"2023","journal-title":"PLOS Comput Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.5808\/gi.23001","article-title":"Computational approaches for molecular characterization and structure-based functional elucidation of a hypothetical protein from Mycobacterium tuberculosis","volume":"21","author":"Saikat","year":"2023","journal-title":"Genomics Inform."},{"key":"B72","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","article-title":"Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis","volume":"181","author":"Bertholet","year":"2008","journal-title":"J Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41591-022-02110-9","article-title":"T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection","volume":"29","author":"Musvosvi","year":"2023","journal-title":"Nat Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1016\/j.vaccine.2023.10.026","article-title":"Conference report: WHO meeting report on mRNA-based tuberculosis vaccine development","volume":"41","author":"Looney","year":"2023","journal-title":"Vaccine"},{"key":"B75","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.193.3.271","article-title":"The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice","volume":"193","author":"Mogues","year":"2001","journal-title":"J Exp Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1089\/aid.2012.0028","article-title":"CD4 T cell depletion exacerbates acute Mycobacterium tuberculosis while reactivation of latent infection is dependent on severity of tissue depletion in cynomolgus macaques AIDS","volume":"28","author":"Lin","year":"2012","journal-title":"Res Hum Retroviruses."},{"key":"B77","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1086\/426827","article-title":"How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners","volume":"191","author":"Sonnenberg","year":"2005","journal-title":"J Infect Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.00042-10","article-title":"HIV tuberculosis: a deadly human syndemic","volume":"24","author":"Kwan","year":"2011","journal-title":"Clin Microbiol Rev."},{"key":"B79","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/ng.590","article-title":"Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved","volume":"42","author":"Comas","year":"2010","journal-title":"Nat Genet."},{"key":"B80","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.chom.2015.10.008","article-title":"M. tuberculosis T cell epitope analysis reveals paucity of antigenic variation and identifies rare variable TB antigens","volume":"18","author":"Coscolla","year":"2015","journal-title":"Cell Host Microbe."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.05.583634","article-title":"Rare Variable M. tuberculosis. Antigens induce predominant Th17 responses in human infection","author":"Ogongo","year":"2024","journal-title":"bioRxiv 2024.03.05.583634."},{"key":"B82","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.chom.2017.05.012","article-title":"Antigen availability shapes T cell differentiation and function during tuberculosis","volume":"21","author":"Moguche","year":"2017","journal-title":"Cell Host Microbe."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1303505","DOI":"10.3389\/ftubr.2023.1303505","article-title":"Recognition and control of Mycobacterium tuberculosis-infected cells: from basics to the clinic: a NIAID\/WGNV workshop report 2023","volume":"1","author":"Young","year":"2023","journal-title":"Front Tubercul."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant bacille calmette-gu\u00e9rin vaccine VPM1002: ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1016\/j.vaccine.2021.06.049","article-title":"a live TB vaccine poised to initiate efficacy trials 100 years after BCG","volume":"39","author":"Mart\u00edn","year":"2021","journal-title":"Vaccine."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e012567","DOI":"10.1136\/bmjopen-2016-012567","article-title":"Risk of tuberculosis in patients treated with TNF-\u03b1 antagonists: a systematic review and meta-analysis of randomised controlled trials","volume":"7","author":"Zhang","year":"2017","journal-title":"BMJ Open."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e87340","DOI":"10.1371\/journal.pone.0087340","article-title":"The candidate TB vaccine, MVA85A, induces highly durable Th1 responses","volume":"9","author":"Tameris","year":"2014","journal-title":"PLoS ONE."},{"key":"B90","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1146\/annurev-immunol-093019-125148","article-title":"The tuberculous granuloma and preexisting immunity","volume":"40","author":"Cohen","year":"2022","journal-title":"Annu Rev Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"101096","DOI":"10.1016\/j.xcrm.2023.101096","article-title":"Blood transcriptional correlates of BCG-induced protection against tuberculosis in rhesus macaques","volume":"4","author":"Liu","year":"2023","journal-title":"Cell Rep Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"585359","DOI":"10.3389\/fimmu.2020.585359","article-title":"Rescuing ESAT-6 specific CD4 T cells from terminal differentiation is critical for long-term control of murine Mtb infection","volume":"11","author":"Clemmensen","year":"2020","journal-title":"Front Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e1006687","DOI":"10.1371\/journal.ppat.1006687","article-title":"Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease","volume":"13","author":"Scriba","year":"2017","journal-title":"PLoS Pathog."},{"key":"B96","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41590-021-00933-1","article-title":"Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease","volume":"22","author":"Nathan","year":"2021","journal-title":"Nat Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41586-018-0439-x","article-title":"A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes","volume":"560","author":"Chowdhury","year":"2018","journal-title":"Nature."},{"key":"B98","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/mi.2012.135","article-title":"Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis","volume":"6","author":"Gopal","year":"2013","journal-title":"Mucosal Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4049\/jimmunol.196.Supp.68.9","article-title":"Inducible bronchus-associated lymphoid tissue plays an important role in the induction of antigen-specific immune response by Ag85B-hPIV2-based anti-tuberculosis vaccine in mice","volume":"196","author":"Nagatake","year":"2016","journal-title":"J Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e00226","DOI":"10.1128\/mBio.00226-21","article-title":"In Vivo Antigen Expression Regulates CD4 T Cell Differentiation and Vaccine Efficacy against Mycobacterium tuberculosis Infection","volume":"12","author":"Clemmensen","year":"2021","journal-title":"MBio."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.celrep.2018.04.003","article-title":"STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection","volume":"23","author":"Van Dis","year":"2018","journal-title":"Cell Rep."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/s41385-018-0065-9","article-title":"Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4+ memory T cells that are associated with protection against tuberculosis","volume":"11","author":"Fl\u00f3rido","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41541-020-00255-7","article-title":"Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis","volume":"5","author":"Counoupas","year":"2020","journal-title":"NPJ Vaccines."},{"key":"B104","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41385-018-0109-1","article-title":"Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1- CD4+ T cells","volume":"12","author":"Bull","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"100400","DOI":"10.1016\/j.jvacx.2023.100400","article-title":"Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications","volume":"15","author":"Gyu-Choi","year":"2023","journal-title":"Vaccine X."},{"key":"B106","doi-asserted-by":"publisher","first-page":"740117","DOI":"10.3389\/fimmu.2021.740117","article-title":"Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics","volume":"12","author":"Enriquez","year":"2021","journal-title":"Front Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/vaccines12010038","article-title":"Enhancing TB vaccine efficacy: current progress on vaccines, adjuvants and immunization strategies","volume":"12","author":"Wang","year":"2023","journal-title":"Vaccines (Basel)."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e1005667","DOI":"10.1371\/journal.ppat.1005667","article-title":"CD4 T cell-derived IFN-\u03b3 plays a minimal role in control of pulmonary Mycobacterium tuberculosis infection and must be actively repressed by PD-1 to prevent lethal disease","volume":"12","author":"Sakai","year":"2016","journal-title":"PLoS Pathog."},{"key":"B109","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1016\/j.celrep.2017.03.007","article-title":"Th1 differentiation drives the accumulation of intravascular, non-protective CD4 T cells during tuberculosis","volume":"18","author":"Sallin","year":"2017","journal-title":"Cell Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.immuni.2022.04.004","article-title":"Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control","volume":"55","author":"Gideon","year":"2022","journal-title":"Immun."},{"key":"B111","doi-asserted-by":"publisher","first-page":"137858","DOI":"10.1172\/jci.insight.137858","article-title":"Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment","volume":"5","author":"Shanmugasundaram","year":"2020","journal-title":"JCI Insight."},{"key":"B112","doi-asserted-by":"publisher","first-page":"13894","DOI":"10.1038\/ncomms13894","article-title":"Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy","volume":"7","author":"Griffiths","year":"2016","journal-title":"Nat Commun."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1101\/2023.02.23.529651","article-title":"A novel adjuvant formulation induces robust Th1\/Th17 memory and mucosal recall responses in Non-Human Primates","author":"Woodworth","year":"2023","journal-title":"bioRxiv 2023.02.23.529651."},{"key":"B114","doi-asserted-by":"publisher","first-page":"jiae238","DOI":"10.1093\/infdis\/jiae238","article-title":"Review of the current TB human infection studies for use in accelerating TB vaccine development: a meeting report","volume":"7","author":"Balasingam","year":"2024","journal-title":"J Infect Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1473-3099(24)00143-9","article-title":"Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial","volume":"2","author":"Satti","year":"2024","journal-title":"Lancet Infect Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fimmu.2019.00992","article-title":"Lung Tissue Resident Memory T-Cells in the Immune Response to Mycobacterium tuberculosis","volume":"10","author":"Ogongo","year":"2019","journal-title":"Front Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"142014","DOI":"10.1172\/JCI142014","article-title":"Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung","volume":"131","author":"Ogongo","year":"2021","journal-title":"J Clin Invest."},{"key":"B118","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(22)00073-1","article-title":"Worrying lack of funding for tuberculosis","volume":"22","author":"Venkatesan","year":"2022","journal-title":"Lancet Infect Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"220044","DOI":"10.1183\/16000617.0044-2022","article-title":"End-point definition and trial design to advance tuberculosis vaccine development","volume":"31","author":"Garcia-Basteiro","year":"2022","journal-title":"Eur Respir Rev."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/infdis\/jiad356","article-title":"An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials","volume":"228","author":"Hill","year":"2023","journal-title":"J Infect Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1084\/jem.192.3.347","article-title":"Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2","volume":"192","author":"Scanga","year":"2000","journal-title":"J Exp Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med."},{"key":"B124","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4049\/jimmunol.1200061","article-title":"IFN-\u03b3 from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection","volume":"190","author":"Green","year":"2013","journal-title":"J Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/humu.22380","article-title":"IL-12R\u03b21 deficiency: mutation update and description of the IL12RB1 variation database","volume":"34","author":"van de Vosse","year":"2013","journal-title":"Hum Mutat."},{"key":"B126","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.smim.2006.07.010","article-title":"Inborn errors of IL-12\/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features","volume":"18","author":"Filipe-Santos","year":"2006","journal-title":"Semin Immunol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"e100830","DOI":"10.1371\/journal.pone.0100830","article-title":"To achieve an earlier IFN-\u03b3 response is not sufficient to control Mycobacterium tuberculosis infection in mice","volume":"9","author":"Vilaplana","year":"2014","journal-title":"PLoS ONE."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A gamma interferon independent mechanism of CD4 T cell mediated control of M tuberculosis infection in vivo","volume":"7","author":"Gallegos","year":"2011","journal-title":"PLoS Pathog."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e1010721","DOI":"10.1371\/journal.ppat.1010721","article-title":"IFN-\u03b3-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1\u03b1","volume":"18","author":"Van Dis","year":"2022","journal-title":"PLoS Pathog."},{"key":"B130","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN-\u03b3-independent immune markers of Mycobacterium tuberculosis exposure","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"104678","DOI":"10.1016\/j.ebiom.2023.104678","article-title":"IFN-\u03b3 independent markers of Mycobacterium tuberculosis exposure among male South African gold miners","volume":"93","author":"Davies","year":"2023","journal-title":"eBioMedicin."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e1003805","DOI":"10.1371\/journal.ppat.1003805","article-title":"cell production of GM-CSF controls Mycobacterium tuberculosis","volume":"10","author":"Rothchild","year":"2014","journal-title":"PLoS Pathog"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e20165","DOI":"10.1371\/journal.pone.0020165","article-title":"Identification of Mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.4049\/jimmunol.1900984","article-title":"Th22 Cells Are a Major Contributor to the Mycobacterial CD4+ T Cell Response and Are Depleted During HIV Infection","volume":"207","author":"Bunjun","year":"2021","journal-title":"J Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"e1004099","DOI":"10.1371\/journal.ppat.1004099","article-title":"Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection","volume":"10","author":"Gopal","year":"2014","journal-title":"PLoS Pathog."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/s41564-018-0231-6","article-title":"Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression","volume":"3","author":"Sallin","year":"2018","journal-title":"Nat Microbiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"e20222090","DOI":"10.1084\/jem.20222090","article-title":"CD30 co-stimulation drives differentiation of protective T cells during Mycobacterium tuberculosis infection","volume":"220","author":"Foreman","year":"2023","journal-title":"J Exp Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"e20230547","DOI":"10.1084\/jem.20230547","article-title":"TB granuloma: CD30 co-stimulation for CD4+ T cell co-operation","volume":"220","author":"Gress","year":"2023","journal-title":"J Exper Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41385-020-0322-6","article-title":"Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis","volume":"14","author":"Du Bruyn","year":"2021","journal-title":"Mucosal Immunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1172\/JCI65728","article-title":"CXCR5+ T helper cells mediate protective immunity against tuberculosis","volume":"123","author":"Slight","year":"2013","journal-title":"J Clin Invest."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3389\/fimmu.2020.01325","article-title":"Formation of Lung Inducible Bronchus Associated Lymphoid Tissue Is Regulated by Mycobacterium tuberculosis Expressed Determinants","volume":"11","author":"Dunlap","year":"2020","journal-title":"Front Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.4049\/jimmunol.1801135","article-title":"Friend or Foe: The Protective and Pathological Roles of Inducible Bronchus-Associated Lymphoid Tissue in Pulmonary Diseases","volume":"202","author":"Marin","year":"2019","journal-title":"J Immunol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41590-023-01476-3","article-title":"Antigen-specific B cells direct T follicular-like helper cells into lymphoid follicles to mediate Mycobacterium tuberculosis control","volume":"24","author":"Swanson","year":"2023","journal-title":"Nat Immunol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"110896","DOI":"10.1016\/j.celrep.2022.110896","article-title":"CD4 T cells are rapidly depleted from tuberculosis granulomas following acute SIV co-infection","volume":"39","author":"Foreman","year":"2022","journal-title":"Cell Rep."},{"key":"B145","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/mi.2017.60","article-title":"Defective positioning in granulomas but not lung-homing limits CD4 T-cell interactions with Mycobacterium tuberculosis-infected macrophages in rhesus macaques","volume":"11","author":"Kauffman","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3337492\/v1","author":"Krause","year":"2023","journal-title":"B Cell Heterogeneity in Human Tuberculosis Highlights Compartment-Specific Phenotype and Putative Functional Roles"},{"key":"B147","doi-asserted-by":"publisher","first-page":"e74419","DOI":"10.7554\/eLife.74419","article-title":"Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice","volume":"11","author":"Smith","year":"2022","journal-title":"Elife."},{"key":"B148","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"Lin","year":"2014","journal-title":"Nat Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/IAI.73.1.546-551.2005","article-title":"Replication dynamics of Mycobacterium tuberculosis in chronically infected mice","volume":"73","author":"Mu\u00f1oz-El\u00edas","year":"2005","journal-title":"Infect Immun."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1355983","DOI":"10.3389\/fimmu.2024.1355983","article-title":"Development and application of the direct mycobacterial growth inhibition assay: a systematic review","volume":"15","author":"Painter","year":"2024","journal-title":"Front Immunol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","article-title":"A distinct function of regulatory T cells in tissue","volume":"162","author":"Arpaia","year":"2015","journal-title":"Protection Cell."},{"key":"B152","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.immuni.2015.01.020","article-title":"Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair","volume":"42","author":"Zaiss","year":"2015","journal-title":"Immunity."}],"container-title":["Frontiers in Tuberculosis"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftubr.2024.1435344\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:57:13Z","timestamp":1721365033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftubr.2024.1435344\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":152,"alternative-id":["10.3389\/ftubr.2024.1435344"],"URL":"https:\/\/doi.org\/10.3389\/ftubr.2024.1435344","relation":{},"ISSN":["2813-7868"],"issn-type":[{"value":"2813-7868","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"article-number":"1435344"}}